Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile systemic scleroderma.

A Martini1

  • 1Dipartimento di Scienze Pediatriche, Università di Pavia, IRCCS Policlinico S. Matteo, 27100, Pavia, Italy. amartini@smatteo.pv.it

Current Rheumatology Reports
|September 21, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Network in pediatric rheumatology: the example of pediatric rheumatology international trials organisation.

Georgian medical news·2008
Same author

Aberrant internal carotid artery in the middle ear: two case reports.

B-ENT·2008
Same author

Protection against cisplatin ototoxicity in a Sprague-Dawley rat animal model.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2008
Same author

Macrophage migration inhibitory factor (MIF) and oligoarticular juvenile idiopathic arthritis (o-JIA): association of MIF promoter polymorphisms with response to intra-articular glucocorticoids.

Clinical and experimental rheumatology·2007
Same author

A longitudinal analysis of physical functional disability over the course of juvenile idiopathic arthritis.

Annals of the rheumatic diseases·2007
Same author

Measuring the psychosocial consequences of hearing loss in a working adult population: focus on validity and reliability of the Italian translation of the hearing handicap inventory.

Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale·2007
Same journal

Intensive Care Management of ANCA-associated Vasculitides: a Narrative Review.

Current rheumatology reports·2026
Same journal

The Role of Musculoskeletal Ultrasound in Psoriatic Arthritis: From Preclinical Detection to Treatment Monitoring.

Current rheumatology reports·2026
Same journal

Correction to: Is Gout and Autoinflammatory Disease?

Current rheumatology reports·2026
Same journal

Risks and Management of Glucocorticoid Therapy for Patients with Rheumatic Disease Having Surgery.

Current rheumatology reports·2026
Same journal

Perioperative Management Considerations for Patients with Systemic Lupus Erythematosus.

Current rheumatology reports·2026
Same journal

Management of IgG4-Related Disease.

Current rheumatology reports·2026
See all related articles

Systemic scleroderma in children, though rare, may benefit from new treatments developed for adults. Research suggests microchimerism

Area of Science:

  • Pediatric rheumatology
  • Immunology
  • Genetics

Background:

  • Systemic scleroderma in children is rare and mimics adult disease.
  • Recent advances in understanding adult systemic scleroderma pathogenesis and treatment have emerged.

Purpose of the Study:

  • To explore the potential value of novel etiopathogenetic and therapeutic approaches for childhood-onset systemic scleroderma.

Main Methods:

  • Review of recent findings in adult systemic scleroderma research.
  • Analysis of microchimerism's role in disease pathogenesis.
  • Evaluation of immunoablation and stem cell rescue as potential therapies.

Main Results:

  • Microchimerism is implicated in the pathogenesis of systemic scleroderma.

Related Experiment Videos

  • Immunoablation followed by stem cell rescue shows therapeutic promise in adults.

    • Conclusions:

    • Emerging etiopathogenetic insights and therapeutic strategies for adult systemic scleroderma may be applicable to pediatric cases.
    • Further investigation into microchimerism and stem cell therapies for childhood-onset disease is warranted.